aluates Reports

$ 0.0

Automative

Global AI for Cancer Diagnosis Market Research Report 2026

Published Date: 2026-06-12

Report Code: QYRE-Auto-27L14064

Global AI for Cancer Diagnosis Market Research Report 2023

BUY CHAPTERS

Global AI for Cancer Diagnosis Market Research Report 2026

Code: QYRE-Auto-27L14064

Report

2026-06-12

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lunit

Xilis

Shukun Technology

Kheiron

SkinVision

Infervision

Imagene AI

Oncora Medical

Niramai Health Analytix

Enlitic

Maxwell Plus

Therapixel

IBEX

OrigiMed

Tencent

AI for Cancer Diagnosis Market Size

The global AI for Cancer Diagnosis market was valued at US$ 292 million in 2025 and is anticipated to reach US$ 2163 million by 2032, at a CAGR of 33.6% from 2026 to 2032.

AI for Cancer Diagnosis Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global AI for Cancer Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI for Cancer Diagnosis. The AI for Cancer Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI for Cancer Diagnosis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI for Cancer Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI for Cancer Diagnosis Market Report

Report Metric	Details
Report Name	AI for Cancer Diagnosis Market
Accounted market size in 2025	US$ 292 million
Forecasted market size in 2032	US$ 2163 million
CAGR	33.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Breast Cancer Lung Cancer Prostatic Cancer Others
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lunit Inc, Xilis, Shukun Technology, Kheiron, SkinVision, Infervision, Imagene AI, Oncora Medical, Niramai Health Analytix, Enlitic, Maxwell Plus, Therapixel, Ibex, OrigiMed, Tencent
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI for Cancer Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI for Cancer Diagnosis Market growing?

Ans: The AI for Cancer Diagnosis Market witnessing a CAGR of 33.6% during the forecast period 2026-2032.

What is the AI for Cancer Diagnosis Market size in 2032?

Ans: The AI for Cancer Diagnosis Market size in 2032 will be US$ 2163 million.

Who are the main players in the AI for Cancer Diagnosis Market report?

Ans: The main players in the AI for Cancer Diagnosis Market are Lunit Inc, Xilis, Shukun Technology, Kheiron, SkinVision, Infervision, Imagene AI, Oncora Medical, Niramai Health Analytix, Enlitic, Maxwell Plus, Therapixel, Ibex, OrigiMed, Tencent

What are the Application segmentation covered in the AI for Cancer Diagnosis Market report?

Ans: The Applications covered in the AI for Cancer Diagnosis Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the AI for Cancer Diagnosis Market report?

Ans: The Types covered in the AI for Cancer Diagnosis Market report are Breast Cancer, Lung Cancer, Prostatic Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI for Cancer Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Breast Cancer

1.2.3 Lung Cancer

1.2.4 Prostatic Cancer

1.2.5 Others

1.3 Market by Application

1.3.1 Global AI for Cancer Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI for Cancer Diagnosis Market Perspective (2021–2032)

2.2 Global AI for Cancer Diagnosis Growth Trends by Region

2.2.1 Global AI for Cancer Diagnosis Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI for Cancer Diagnosis Historic Market Size by Region (2021–2026)

2.2.3 AI for Cancer Diagnosis Forecasted Market Size by Region (2027–2032)

2.3 AI for Cancer Diagnosis Market Dynamics

2.3.1 AI for Cancer Diagnosis Industry Trends

2.3.2 AI for Cancer Diagnosis Market Drivers

2.3.3 AI for Cancer Diagnosis Market Challenges

2.3.4 AI for Cancer Diagnosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI for Cancer Diagnosis Players by Revenue

3.1.1 Global Top AI for Cancer Diagnosis Players by Revenue (2021–2026)

3.1.2 Global AI for Cancer Diagnosis Revenue Market Share by Players (2021–2026)

3.2 Global Top AI for Cancer Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI for Cancer Diagnosis Revenue

3.4 Global AI for Cancer Diagnosis Market Concentration Ratio

3.4.1 Global AI for Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI for Cancer Diagnosis Revenue in 2025

3.5 Global Key Players of AI for Cancer Diagnosis Head Offices and Areas Served

3.6 Global Key Players of AI for Cancer Diagnosis, Products and Applications

3.7 Global Key Players of AI for Cancer Diagnosis, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI for Cancer Diagnosis Breakdown Data by Type

4.1 Global AI for Cancer Diagnosis Historic Market Size by Type (2021–2026)

4.2 Global AI for Cancer Diagnosis Forecasted Market Size by Type (2027–2032)

5 AI for Cancer Diagnosis Breakdown Data by Application

5.1 Global AI for Cancer Diagnosis Historic Market Size by Application (2021–2026)

5.2 Global AI for Cancer Diagnosis Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI for Cancer Diagnosis Market Size (2021–2032)

6.2 North America AI for Cancer Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI for Cancer Diagnosis Market Size by Country (2021–2026)

6.4 North America AI for Cancer Diagnosis Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI for Cancer Diagnosis Market Size (2021–2032)

7.2 Europe AI for Cancer Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI for Cancer Diagnosis Market Size by Country (2021–2026)

7.4 Europe AI for Cancer Diagnosis Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI for Cancer Diagnosis Market Size (2021–2032)

8.2 Asia-Pacific AI for Cancer Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2021–2026)

8.4 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI for Cancer Diagnosis Market Size (2021–2032)

9.2 Latin America AI for Cancer Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI for Cancer Diagnosis Market Size by Country (2021–2026)

9.4 Latin America AI for Cancer Diagnosis Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI for Cancer Diagnosis Market Size (2021–2032)

10.2 Middle East & Africa AI for Cancer Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2021–2026)

10.4 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lunit Inc

11.1.1 Lunit Inc Company Details

11.1.2 Lunit Inc Business Overview

11.1.3 Lunit Inc AI for Cancer Diagnosis Introduction

11.1.4 Lunit Inc Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.1.5 Lunit Inc Recent Development

11.2 Xilis

11.2.1 Xilis Company Details

11.2.2 Xilis Business Overview

11.2.3 Xilis AI for Cancer Diagnosis Introduction

11.2.4 Xilis Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.2.5 Xilis Recent Development

11.3 Shukun Technology

11.3.1 Shukun Technology Company Details

11.3.2 Shukun Technology Business Overview

11.3.3 Shukun Technology AI for Cancer Diagnosis Introduction

11.3.4 Shukun Technology Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.3.5 Shukun Technology Recent Development

11.4 Kheiron

11.4.1 Kheiron Company Details

11.4.2 Kheiron Business Overview

11.4.3 Kheiron AI for Cancer Diagnosis Introduction

11.4.4 Kheiron Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.4.5 Kheiron Recent Development

11.5 SkinVision

11.5.1 SkinVision Company Details

11.5.2 SkinVision Business Overview

11.5.3 SkinVision AI for Cancer Diagnosis Introduction

11.5.4 SkinVision Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.5.5 SkinVision Recent Development

11.6 Infervision

11.6.1 Infervision Company Details

11.6.2 Infervision Business Overview

11.6.3 Infervision AI for Cancer Diagnosis Introduction

11.6.4 Infervision Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.6.5 Infervision Recent Development

11.7 Imagene AI

11.7.1 Imagene AI Company Details

11.7.2 Imagene AI Business Overview

11.7.3 Imagene AI AI for Cancer Diagnosis Introduction

11.7.4 Imagene AI Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.7.5 Imagene AI Recent Development

11.8 Oncora Medical

11.8.1 Oncora Medical Company Details

11.8.2 Oncora Medical Business Overview

11.8.3 Oncora Medical AI for Cancer Diagnosis Introduction

11.8.4 Oncora Medical Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.8.5 Oncora Medical Recent Development

11.9 Niramai Health Analytix

11.9.1 Niramai Health Analytix Company Details

11.9.2 Niramai Health Analytix Business Overview

11.9.3 Niramai Health Analytix AI for Cancer Diagnosis Introduction

11.9.4 Niramai Health Analytix Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.9.5 Niramai Health Analytix Recent Development

11.10 Enlitic

11.10.1 Enlitic Company Details

11.10.2 Enlitic Business Overview

11.10.3 Enlitic AI for Cancer Diagnosis Introduction

11.10.4 Enlitic Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.10.5 Enlitic Recent Development

11.11 Maxwell Plus

11.11.1 Maxwell Plus Company Details

11.11.2 Maxwell Plus Business Overview

11.11.3 Maxwell Plus AI for Cancer Diagnosis Introduction

11.11.4 Maxwell Plus Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.11.5 Maxwell Plus Recent Development

11.12 Therapixel

11.12.1 Therapixel Company Details

11.12.2 Therapixel Business Overview

11.12.3 Therapixel AI for Cancer Diagnosis Introduction

11.12.4 Therapixel Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.12.5 Therapixel Recent Development

11.13 Ibex

11.13.1 Ibex Company Details

11.13.2 Ibex Business Overview

11.13.3 Ibex AI for Cancer Diagnosis Introduction

11.13.4 Ibex Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.13.5 Ibex Recent Development

11.14 OrigiMed

11.14.1 OrigiMed Company Details

11.14.2 OrigiMed Business Overview

11.14.3 OrigiMed AI for Cancer Diagnosis Introduction

11.14.4 OrigiMed Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.14.5 OrigiMed Recent Development

11.15 Tencent

11.15.1 Tencent Company Details

11.15.2 Tencent Business Overview

11.15.3 Tencent AI for Cancer Diagnosis Introduction

11.15.4 Tencent Revenue in AI for Cancer Diagnosis Business (2021–2026)

11.15.5 Tencent Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lunit

Xilis

Shukun Technology

Kheiron

SkinVision

Infervision

Imagene AI

Oncora Medical

Niramai Health Analytix

Enlitic

Maxwell Plus

Therapixel

IBEX

OrigiMed

Tencent

List of Tables

Table 1. Global AI for Cancer Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Breast Cancer

Table 3. Key Players of Lung Cancer

Table 4. Key Players of Prostatic Cancer

Table 5. Key Players of Others

Table 6. Global AI for Cancer Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global AI for Cancer Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global AI for Cancer Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 9. Global AI for Cancer Diagnosis Market Share by Region (2021–2026)

Table 10. Global AI for Cancer Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global AI for Cancer Diagnosis Market Share by Region (2027–2032)

Table 12. AI for Cancer Diagnosis Market Trends

Table 13. AI for Cancer Diagnosis Market Drivers

Table 14. AI for Cancer Diagnosis Market Challenges

Table 15. AI for Cancer Diagnosis Market Restraints

Table 16. Global AI for Cancer Diagnosis Revenue by Players (US$ Million), 2021–2026

Table 17. Global AI for Cancer Diagnosis Market Share by Players (2021–2026)

Table 18. Global Top AI for Cancer Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI for Cancer Diagnosis Revenue, 2025

Table 19. Ranking of Global Top AI for Cancer Diagnosis Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by AI for Cancer Diagnosis Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of AI for Cancer Diagnosis, Headquarters and Area Served

Table 22. Global Key Players of AI for Cancer Diagnosis, Products and Applications

Table 23. Global Key Players of AI for Cancer Diagnosis, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global AI for Cancer Diagnosis Market Size by Type (US$ Million), 2021–2026

Table 26. Global AI for Cancer Diagnosis Revenue Market Share by Type (2021–2026)

Table 27. Global AI for Cancer Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global AI for Cancer Diagnosis Revenue Market Share by Type (2027–2032)

Table 29. Global AI for Cancer Diagnosis Market Size by Application (US$ Million), 2021–2026

Table 30. Global AI for Cancer Diagnosis Revenue Market Share by Application (2021–2026)

Table 31. Global AI for Cancer Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global AI for Cancer Diagnosis Revenue Market Share by Application (2027–2032)

Table 33. North America AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America AI for Cancer Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 35. North America AI for Cancer Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 36. Europe AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe AI for Cancer Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 38. Europe AI for Cancer Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific AI for Cancer Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific AI for Cancer Diagnosis Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific AI for Cancer Diagnosis Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America AI for Cancer Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America AI for Cancer Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa AI for Cancer Diagnosis Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa AI for Cancer Diagnosis Market Size by Country (US$ Million), 2027–2032

Table 48. Lunit Inc Company Details

Table 49. Lunit Inc Business Overview

Table 50. Lunit Inc AI for Cancer Diagnosis Product

Table 51. Lunit Inc Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 52. Lunit Inc Recent Development

Table 53. Xilis Company Details

Table 54. Xilis Business Overview

Table 55. Xilis AI for Cancer Diagnosis Product

Table 56. Xilis Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 57. Xilis Recent Development

Table 58. Shukun Technology Company Details

Table 59. Shukun Technology Business Overview

Table 60. Shukun Technology AI for Cancer Diagnosis Product

Table 61. Shukun Technology Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 62. Shukun Technology Recent Development

Table 63. Kheiron Company Details

Table 64. Kheiron Business Overview

Table 65. Kheiron AI for Cancer Diagnosis Product

Table 66. Kheiron Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 67. Kheiron Recent Development

Table 68. SkinVision Company Details

Table 69. SkinVision Business Overview

Table 70. SkinVision AI for Cancer Diagnosis Product

Table 71. SkinVision Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 72. SkinVision Recent Development

Table 73. Infervision Company Details

Table 74. Infervision Business Overview

Table 75. Infervision AI for Cancer Diagnosis Product

Table 76. Infervision Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 77. Infervision Recent Development

Table 78. Imagene AI Company Details

Table 79. Imagene AI Business Overview

Table 80. Imagene AI AI for Cancer Diagnosis Product

Table 81. Imagene AI Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 82. Imagene AI Recent Development

Table 83. Oncora Medical Company Details

Table 84. Oncora Medical Business Overview

Table 85. Oncora Medical AI for Cancer Diagnosis Product

Table 86. Oncora Medical Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 87. Oncora Medical Recent Development

Table 88. Niramai Health Analytix Company Details

Table 89. Niramai Health Analytix Business Overview

Table 90. Niramai Health Analytix AI for Cancer Diagnosis Product

Table 91. Niramai Health Analytix Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 92. Niramai Health Analytix Recent Development

Table 93. Enlitic Company Details

Table 94. Enlitic Business Overview

Table 95. Enlitic AI for Cancer Diagnosis Product

Table 96. Enlitic Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 97. Enlitic Recent Development

Table 98. Maxwell Plus Company Details

Table 99. Maxwell Plus Business Overview

Table 100. Maxwell Plus AI for Cancer Diagnosis Product

Table 101. Maxwell Plus Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 102. Maxwell Plus Recent Development

Table 103. Therapixel Company Details

Table 104. Therapixel Business Overview

Table 105. Therapixel AI for Cancer Diagnosis Product

Table 106. Therapixel Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 107. Therapixel Recent Development

Table 108. Ibex Company Details

Table 109. Ibex Business Overview

Table 110. Ibex AI for Cancer Diagnosis Product

Table 111. Ibex Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 112. Ibex Recent Development

Table 113. OrigiMed Company Details

Table 114. OrigiMed Business Overview

Table 115. OrigiMed AI for Cancer Diagnosis Product

Table 116. OrigiMed Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 117. OrigiMed Recent Development

Table 118. Tencent Company Details

Table 119. Tencent Business Overview

Table 120. Tencent AI for Cancer Diagnosis Product

Table 121. Tencent Revenue in AI for Cancer Diagnosis Business (US$ Million), 2021–2026

Table 122. Tencent Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. AI for Cancer Diagnosis Picture

Figure 2. Global AI for Cancer Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI for Cancer Diagnosis Market Share by Type: 2025 vs 2032

Figure 4. Breast Cancer Features

Figure 5. Lung Cancer Features

Figure 6. Prostatic Cancer Features

Figure 7. Others Features

Figure 8. Global AI for Cancer Diagnosis Market Size by Application (US$ Million), 2021–2032

Figure 9. Global AI for Cancer Diagnosis Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Other Case Studies

Figure 13. AI for Cancer Diagnosis Report Years Considered

Figure 14. Global AI for Cancer Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global AI for Cancer Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global AI for Cancer Diagnosis Market Share by Region: 2025 vs 2032

Figure 17. Global AI for Cancer Diagnosis Market Share by Players in 2025

Figure 18. Global AI for Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by AI for Cancer Diagnosis Revenue in 2025

Figure 20. North America AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America AI for Cancer Diagnosis Market Share by Country (2021–2032)

Figure 22. United States AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe AI for Cancer Diagnosis Market Share by Country (2021–2032)

Figure 26. Germany AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific AI for Cancer Diagnosis Market Share by Region (2021–2032)

Figure 34. China AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America AI for Cancer Diagnosis Market Share by Country (2021–2032)

Figure 42. Mexico AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa AI for Cancer Diagnosis Market Share by Country (2021–2032)

Figure 46. Israel AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE AI for Cancer Diagnosis Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Lunit Inc Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 50. Xilis Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 51. Shukun Technology Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 52. Kheiron Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 53. SkinVision Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 54. Infervision Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 55. Imagene AI Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 56. Oncora Medical Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 57. Niramai Health Analytix Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 58. Enlitic Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 59. Maxwell Plus Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 60. Therapixel Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 61. Ibex Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 62. OrigiMed Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 63. Tencent Revenue Growth Rate in AI for Cancer Diagnosis Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

AI for Early Cancer Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Automated Clinical Diagnostic System Market Research Report 2024

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Pharma Market Research Report 2025

Global Kidney Cancer Diagnosis Market Research Report 2025

Global Artificial Intelligence In Diagnostic Market Research Report 2024

Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions